Research
The Clinical Epidemiology Group is investigating potentially remediable aetiologic and prognostic factors for specific coronary disease phenotypes.
In the CArdiovascular disease research LInking Bespoke studies and Electronic Records (CALIBER) consortium, funded by the Wellcome Trust, we are exploiting large scale resources such as the national register of acute coronary syndromes, linked to the primary care record, and investigator led ("bespoke") studies, which collect DNA and other exposures, (e.g. Whitehall II).
Funder by our NIHR programme grant, the Clinical Cohorts in Coronary disease Collaboration (4C) is phenotyping and genotyping people with suspected and confirmed stable coronary disease, with follow up for coronary endpoints.
The MRC funded Prognosis Research Strategy initiative (PROGRESS) is an international, interdisciplinary collaboration developing understanding in research into prognostic factors, risk prediction models and predictors of differential treatment response.
